0001209191-16-091745.txt : 20160115 0001209191-16-091745.hdr.sgml : 20160115 20160115164158 ACCESSION NUMBER: 0001209191-16-091745 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151215 FILED AS OF DATE: 20160115 DATE AS OF CHANGE: 20160115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gergel Ivan P. CENTRAL INDEX KEY: 0001328288 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 161345895 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 455 MISSION BAY BLVD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER NAME: FORMER CONFORMED NAME: Gergel Ivan DATE OF NAME CHANGE: 20050525 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2015-12-15 2015-12-17 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001328288 Gergel Ivan P. C/O NEKTAR THERAPEUTICS 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 0 1 0 0 SVP & Chief Medical Officer Restricted Stock Unit 2015-12-15 4 A 0 15000 0.00 A 2023-12-14 Common Stock 15000 15000 D Stock Option 15.55 2015-12-15 4 A 0 12500 0.00 A 2023-12-14 Common Stock 12500 12500 D Each restricted stock unit represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. This restricted stock unit vests over 3 years in equal quarterly installments. This stock option vests in equal monthly installments over the 4-year period following the grant date. Gil M. Labrucherie, Attorney-in-Fact 2016-01-15